Senior Scientist, Toxicology Data & Safety Strategy

Eli Lilly and Company; Indianapolis (IN); On-site; USD 66,000 - 189,000; Full time

Benefits offered by this job

Company bonus

401(k) plan

Health benefits

Job summary

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is seeking a Senior Scientist to lead safety analytics across nonclinical data and own the SEND data audit and visualization pipeline for regulatory support.

This 100% non-laboratory role interfaces with PDTs and cross-functional teams (DMPK, CMC, Regulatory, Clinical Operations) to shape risk assessments and investigative toxicity strategies. Strong writing and influence are essential.

Qualifications

• B.S. or M.S. in Toxicology, Pharmacology, Cellular/Molecular Biology, Bioinformatics, or a related life sciences discipline.
• With an M.S. degree: 6-8+ years of relevant biotechnology/pharma/CRO experience.
• With a B.S. degree: 8-10+ years of industrial drug-development, data management, and toxicology ops experience.

Responsibilities

• Lead data models that transform multi-dose toxicology data, pathology tables, and safety metrics into publication-ready visuals.
• Audit SEND datasets from CRO vendors for regulatory filing and archival.
• Synthesize literature to assess safety risks and inform investigative toxicity strategies.
• Co-author data packages, briefing books, and governance materials with Toxicology Leads.
• Coordinate with Safety Assessment, DMPK, CMC and PDTs to map nonclinical safety deliverables to milestones.

Skills

Data visualization

Data analysis

SEND data auditing

Cross-functional leadership

Scientific writing

Education

B.S. in Toxicology or related

M.S. in Toxicology or related

Tools

GraphPad Prism

Spotfire

Excel macros

Python/R data tools

Job description

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is seeking a Senior Scientist to lead safety analytics across nonclinical data and own the SEND data audit and visualization pipeline for regulatory support.

This 100% non-laboratory role interfaces with PDTs and cross-functional teams (DMPK, CMC, Regulatory, Clinical Operations) to shape risk assessments and investigative toxicity strategies. Strong writing and influence are essential.